Výsledky vyhledávání - Henk P. Swart
- Zobrazuji výsledky 1 - 5 z 5
-
1
Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐... Autor Kevin Damman, Joost C. Beusekamp, Eva M. Boorsma, Henk P. Swart, Tom D.J. Smilde, Arif Elvan, J.W. Martijn van Eck, Hiddo J.L. Heerspink, Adriaan A. Voors
Vydáno 2020Artigo -
2
Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial Autor Adriaan A. Voors, Jean‐François Tamby, John G.F. Cleland, Michael J. Koren, Leslie B. Forgosh, Dinesh Gupta, Lars H. Lund, Albert Camacho, Ravi Karra, Henk P. Swart, Pierpaolo Pellicori, Frank Wagner, Ray E. Hershberger, Narayana Prasad, Robert L. Anderson, Anu Anto, Kaylyn M. Bell, Jay M. Edelberg, Liang Fang, Marcus Henze, Cynthia M. Kelly, Gregory Kurio, Wanying Li, Kate Wells, Chun Yang, Sam L. Teichman, Carlos del Río, Scott D. Solomon
Vydáno 2020Artigo -
3
Colchicine in Patients with Chronic Coronary Disease Autor Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd, John W. Eikelboom, Astrid Schut, Tjerk S.J. Opstal, Salem H.K. The, Xiao-Fang Xu, Mark A. Ireland, Timo Lenderink, Donald Latchem, Pieter Hoogslag, Anastazia Jerzewski, Peter R Nierop, Alan Whelan, Randall Hendriks, Henk P. Swart, Jeroen Schaap, Aaf F.M. Kuijper, M. W. J. van Hessen, Pradyot Saklani, Isabel Tan, Angus Thompson, Allison Morton, Chris Judkins, Willem A. Bax, Maurits T. Dirksen, Marco Alings, Graeme J. Hankey, Charley A. Budgeon, Jan G.P. Tijssen, Jan H. Cornel, Peter L. Thompson
Vydáno 2020Artigo -
4
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease Autor Harvey D. White, Claes Held, Ralph Stewart, Elizabeth Tarka, R. G. Brown, Richard Y. Davies, Andrzej Budaj, Robert A. Harrington, Philippe Gabríel Steg, Diego Ardissino, Paul W. Armstrong, Álvaro Avezum, Philip E. Aylward, Alfonso Bryce, Hong Chen, Ming Fong Chen, Ramón Corbalán, Anthony J. Dalby, Nicolas Danchin, Robbert J. de Winter, Stefan Denchev, Rafael Díaz, Moses Elisaf, Marcus Flather, Assen Goudev, C. B. Granger, Liliana Grinfeld, Judith S. Hochman, Steen Husted, Hyo Soo Kim, Wolfgang Köenig, Aleš Linhart, Eva Lonn, J. Lopez-Sendon, Athanasios Manolis, Emile R. Mohler, José Carlos Nicolau, Prem Pais, Alexander Parkhomenko, Terje R. Pedersen, Daniel Pella, Marco Antonio Ramos-Corrales, Mikhail Ruda, Mátyás Sereg, Saulat Siddique, Peter Sinnaeve, Peter Smith, Piyamitr Sritara, Henk P. Swart, Rody G. Sy, Tamio Teramoto, Hung‐Fat Tse, David F. Watson, W. Douglas Weaver, Robert Weiss, Margus Viigimaa, Dragoş Vinereanu, Junren Zhu, Christopher P. Cannon, Lars Wallentin
Vydáno 2014Artigo -
5
Lipoprotein‐Associated Phospholipase A <sub>2</sub> Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease Autor Lars Wallentin, Claes Held, Paul W. Armstrong, Christopher P. Cannon, Richard Y. Davies, Christopher B. Granger, Emil Hagström, Robert A. Harrington, Judith S. Hochman, Wolfgang Köenig, Sue Krug‐Gourley, Emile R. Mohler, Agneta Siegbahn, Elizabeth Tarka, Philippe Gabríel Steg, Ralph Stewart, Robert Weiss, Ollie Östlund, Harvey D. White, Andrzej Budaj, Diego Ardissino, Álvaro Avezum, Philip E. Aylward, Alfonso Bryce, Hong Chen, Ming‐Fong Chen, Ramón Corbalán, Anthony J. Dalby, Nicolas Danchin, Robbert J. de Winter, Stefan Denchev, Rafael Díaz, Moses Elisaf, Marcus Flather, Assen Goudev, Liliana Grinfeld, Steen Husted, Hyo‐Soo Kim, Aleš Linhart, Eva Lonn, José López‐Sendón, Athanasios Manolis, José Carlos Nicolau, Prem Pais, Alexander Parkhomenko, Terje R. Pedersen, Daniel Pella, Marco Antonio Ramos-Corrales, Mikhail Ruda, Mátyás Sereg, Saulat Siddique, Peter Sinnaeve, Piyamitr Sritara, Henk P. Swart, Rody G. Sy, Tamio Teramoto, Hung‐Fat Tse, W. Douglas Weaver, Margus Viigimaa, Dragoş Vinereanu, Junren Zhu
Vydáno 2016Artigo
Vyhledávací nástroje:
Související témata
Cardiology
Internal medicine
Medicine
Alternative medicine
Clinical endpoint
Heart failure
Myocardial infarction
Pathology
Placebo
Adverse effect
Confidence interval
Hazard ratio
Randomized controlled trial
Acute decompensated heart failure
Anesthesia
Angina
Cholesterol
Clinical trial
Colchicine
Coronary artery disease
Coronary atherosclerosis
Coronary disease
Coronary heart disease
Diabetes mellitus
Disease
Diuretic
Ejection fraction
Empagliflozin
Endocrinology
Furosemide